Landers v. Merck Sharp & Dohme Corp. et al
Landers and Krista Landers |
Merck Sharp & Dohme Corp, Merck Sharp & Dohme Corp. nka Merck Sharp & Dohme LLC and Merck & Co., Inc. |
ILN/1:22-CV-01696 |
April 1, 2022 |
Judicial Panel on Multidistrict Litigation |
Thomas M Durkin |
Other |
Docket Report
This docket was last retrieved on May 25, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 16 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. ( #45 in MDL No. 3036) ) Motion of Plaintiffs Sahara Walker, et al. for Extension of Time to Reply to Response -- GRANTED IN PART. Reply, if any, due on or before 6/3/2022. Signed by Clerk of the Panel John W. Nichols on 5/25/2022. Associated Cases: MDL No. 3036, AZ/2:20-cv-01425, AZ/2:22-cv-00398, AZ/2:22-cv-00420, CAC/2:22-cv-01739, CAC/8:22-cv-00422, CAC/8:22-cv-00431, CAS/3:21-cv-00120, CT/3:21-cv-00438, FLM/8:21-cv-01814, FLM/8:21-cv-02903, FLN/3:21-cv-01335, FLS/9:22-cv-80445, GAN/1:22-cv-01171, GAN/1:22-cv-01178, HI/1:22-cv-00144, ILC/4:21-cv-04154, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, MA/3:22-cv-10006, MIE/5:21-cv-12324, NCM/1:22-cv-00212, NCW/3:22-cv-00117, NCW/5:22-cv-00030, NJ/3:22-cv-00116, NV/3:21-cv-00166, OHN/5:22-cv-00619, RI/1:20-cv-00364, SC/2:21-cv-02211, TXE/6:21-cv-00506, TXN/4:22-cv-00241, WIW/3:20-cv-01048, WVS/2:22-cv-00160 (JN) |
Filing 15 CERTIFICATE OF SERVICE re: pldg. ( #40 in MDL No. 3036) Filed by Plaintiffs Scott Wagner, #et al.Tanja Wagner, Ken Wingerter, Shaun Wingerter, Nalon A. Soileau, Darby Hendrix, Jessica R aymer, Madelyn Lipscomb, Mackenzie Pennell, Krista Landers #[Suppress List] -- Associated Cases: MDL No. 3036, GAN/1:22-cv-01171, GAN/1:22-cv-01178, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, OHN/5:22-cv-00619 (Coffin, Christopher) |
Filing 14 RESPONSE IN SUPPORT WITH INTERESTED PARTIES -- (re: pldg. ( #1 in MDL No. 3036) ) Filed by Plaintiffs Scott Wagner, #et al.Tanja Wagner, Ken Wingerter, Shaun Wingerter, Nalon A. Soileau, Darby Hendrix, Jessica Raymer, Madelyn Lipscomb, Mackenzie Pennell, Krista Landers #[Suppress List] Associated Cases: MDL No. 3036, GAN/1:22-cv-01171, GAN/1:22-cv-01178, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, OHN/5:22-cv-00619 (Coffin, Christopher) EDITED EVENT TYPE Modified on 5/24/2022 (CMD). |
Filing 13 CORPORATE DISCLOSURE STATEMENT (AMENDED) - re: pldg. (5 in AZ/2:20-cv-01425, 5 in AZ/2:22-cv-00398, 5 in AZ/2:22-cv-00420, 5 in CAC/2:22-cv-01739, 5 in CAC/8:22-cv-00422, 5 in CAC/8:22-cv-00431, 5 in CAS/3:21-cv-00120, 5 in FLM/8:21-cv-01814, 5 in FLM/8:21-cv-02903, 5 in FLN/3:21-cv-01335, 5 in FLS/9:22-cv-80445, 5 in GAN/1:22-cv-01171, 5 in GAN/1:22-cv-01178, 5 in HI/1:22-cv-00144, 5 in ILC/4:21-cv-04154, 5 in ILN/1:22-cv-01643, 5 in ILN/1:22-cv-01696, 5 in ILN/1:22-cv-01717, 5 in INN/1:22-cv-00116, 5 in LAM/3:22-cv-00210, 5 in MA/3:22-cv-10006, #8 in MDL No. 3036, 5 in MIE/5:21-cv-12324, 5 in NCM/1:22-cv-00212, 5 in NCW/3:22-cv-00117, 5 in NCW/5:22-cv-00030, 5 in NJ/3:22-cv-00116, 5 in NV/3:21-cv-00166, 5 in RI/1:20-cv-00364, 5 in SC/2:21-cv-02211, 5 in TXE/6:21-cv-00506, 5 in TXN/4:22-cv-00241, 5 in WIW/3:20-cv-01048, 5 in WVS/2:22-cv-00160), (6 in AZ/2:20-cv-01425, 6 in AZ/2:22-cv-00398, 6 in AZ/2:22-cv-00420, 6 in CAC/2:22-cv-01739, 6 in CAC/8:22-cv-00422, 6 in CAC/8:22-cv-00431, 6 in CAS/3:21-cv-00120, 6 in FLM/8:21-cv-01814, 6 in FLM/8:21-cv-02903, 6 in FLN/3:21-cv-01335, 6 in FLS/9:22-cv-80445, 6 in GAN/1:22-cv-01171, 6 in GAN/1:22-cv-01178, 6 in HI/1:22-cv-00144, 6 in ILC/4:21-cv-04154, 6 in ILN/1:22-cv-01643, 6 in ILN/1:22-cv-01696, 6 in ILN/1:22-cv-01717, 6 in INN/1:22-cv-00116, 6 in LAM/3:22-cv-00210, 6 in MA/3:22-cv-10006, 9 in MDL No. 3036, 6 in MIE/5:21-cv-12324, 6 in NCM/1:22-cv-00212, 6 in NCW/3:22-cv-00117, 6 in NCW/5:22-cv-00030, 6 in NJ/3:22-cv-00116, 6 in NV/3:21-cv-00166, 6 in RI/1:20-cv-00364, 6 in SC/2:21-cv-02211, 6 in TXE/6:21-cv-00506, 6 in TXN/4:22-cv-00241, 6 in WIW/3:20-cv-01048, 6 in WVS/2:22-cv-00160) Identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. nka Merck Sharp & Dohme LLC Corporate Parent No Parent Corp. for Merck & Co., Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) EDITED CORP. PARENT & DELETED DUPLICATE PARTY NAMES Modified on 5/24/2022 (CMD). |
Filing 12 RESPONSE IN OPPOSITION -- (re: pldg. ( #1 in MDL No. 3036), ( 17 in MDL No. 3036), ( 20 in MDL No. 3036)) Filed by Defendants Merck & Co, Inc., Merck Sharp & Dohme Corp. (Attachments: #1 Declaration of Allyson Julien, #2 Exhibit A - Gardasil Patient Information, #3 Exhibit B - Sample Package Inserts, #4 Exhibit C - Safety Information for HPV Vaccine, CDC, #5 Exhibit D - HPV Vaccination and Cancer Prevention, CDC, #6 Exhibit E - Reasons to Get HPV Vaccine, CDC, #7 Exhibit F - Cervical cancer, WHO, #8 Exhibit G - Lei 2020, #9 Exhibit H - Kjaer 2021, #10 Exhibit I - Falcaro 2021, #11 Exhibit J - Lehtinen 2021, #12 Exhibit K - Tabibi 2021, #13 Exhibit L - Berenson 2022, #14 Exhibit M - ACOG Joint Statement on HPV, #15 Exhibit N - HPV Vaccine Safety, CDC, #16 Exhibit O - Gardasil Vaccine Safety, FDA, #17 Exhibit P - Balasco Joint Motion to Amend Scheduling Order, #18 Exhibit Q - Stratton Amended Scheduling Order, #19 Exhibit R - Herlth Opinion Slip Copy, #20 Exhibit S - MDL Conference Agenda, #21 Exhibit T - New York Times Article, #22 Exhibit U - Office for Science and Society Article, #23 Exhibit V - New York Times Article, #24 Exhibit W - Jamison 2020, #25 Exhibit X - Children's Health Defense Webpage, #26 Exhibit Y - Adjuvants and Vaccines, CDC, #27 Exhibit Z - Information on Gardasil Presence of DNA Fragments Expected, No Safety Risk, FDA, #28 Exhibit AA - Parent Concerns About HPV Vaccine Safety Increasing, NCI, #29 Exhibit BB - Ten threats to global health in 2019, WHO, #30 Exhibit CC - Advisory Committee on Civil Rules Agenda, #31 Exhibit DD - Shain - Hearing transcript, #32 Exhibit EE - HRSA Data and Statistics, #33 Exhibit FF - Counts v Secretary of HHS Docket, #34 Exhibit GG - Fetters v. Secretary of HHS Docket, #35 Exhibit HH - Gramza Ex Parte Application for Modified Scheduling Order, #36 Schedule of Actions, #37 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) EDITED MDL LINKS; DELETED DUPLICATE PARTY NAMES Modified on 5/23/2022 (CMD). Modified on 5/25/2022 (CMD). |
Filing 11 NOTICE OF APPEARANCE (CORRECTED) re: pldg.( #1 in MDL No. 3036, 16 in MDL No. 3036, 20 in MDL No. 3036) Filed by Christopher L. Coffin on behalf of Plaintiffs Scott Wagner, #et al.Tanja Wagner, Ken Wingerter, Shaun Wingerter, Nalon A. Soileau, Darby Hendrix, Jessica Raymer, Madelyn Lipscomb, Mackenzie Pennell, Krista Landers #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036, GAN/1:22-cv-01171, GAN/1:22-cv-01178, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, OHN/5:22-cv-00619 (Coffin, Christopher) EDITED EVENT TYPE & ADDED MDL LINKS Modified on 5/3/2022 (CMD). |
Filing 10 SEE CORRECTED PLDG. 22NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 3036) Filed by Tracy L. Turner on behalf of Plaintiffs Scott Wagner, #et al.Tanja Wagner, Liaison Counsel for Plaintiffs, Ken Wingerter, Shaun Wingerter, Nalon A. Soileau, Darby Hendrix, Jessica Raymer, Madelyn Lipscomb, Krista Landers #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036, GAN/1:22-cv-01171, GAN/1:22-cv-01178, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210 (Turner, Tracy) Modified on 5/3/2022 (CMD). |
Filing 9 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. ( #10 in MDL No. 3036) ) -- Motion of: Defendants Merck & Co., Inc., and Merck Sharp & Dohme Corp. for Extensi on of Time to File Response -- GRANTED TO ALL PARTIES. Responses due on or before 5/20/2022. Reply, if any, due on or before 5/27/2022. Signed by Clerk of the Panel John W. Nichols on 4/21/2022. Associated Cases: MDL No. 3036, AZ/2:20-cv-01425, AZ/2:22-cv-00398, AZ/2:22-cv-00420, CAC/2:22-cv-01739, CAC/8:22-cv-00422, CAC/8:22-cv-00431, CAS/3:21-cv-00120, FLM/8:21-cv-01814, FLM/8:21-cv-02903, FLN/3:21-cv-01335, FLS/9:22-cv-80445, GAN/1:22-cv-01171, GAN/1:22-cv-01178, HI/1:22-cv-00144, ILC/4:21-cv-04154, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, MA/3:22-cv-10006, MIE/5:21-cv-12324, NCM/1:22-cv-00212, NCW/3:22-cv-00117, NCW/5:22-cv-00030, NJ/3:22-cv-00116, NV/3:21-cv-00166, RI/1:20-cv-00364, SC/2:21-cv-02211, TXE/6:21-cv-00506, TXN/4:22-cv-00241, WIW/3:20-cv-01048, WVS/2:22-cv-00160 (JN) |
Filing 8 ERRATA - to (7 in AZ/2:20-cv-01425, 7 in AZ/2:22-cv-00398, 7 in AZ/2:22-cv-00420, 7 in CAC/2:22-cv-01739, 7 in CAC/8:22-cv-00422, 7 in CAC/8:22-cv-00431, 7 in CAS/3:21-cv-00120, 2 in CT/3:21-cv-00438, 7 in FLM/8:21-cv-01814, 7 in FLM/8:21-cv-02903, 7 in FLN/3:21-cv-01335, 7 in FLS/9:22-cv-80445, 7 in GAN/1:22-cv-01171, 7 in GAN/1:22-cv-01178, 7 in HI/1:22-cv-00144, 7 in ILC/4:21-cv-04154, 7 in ILN/1:22-cv-01643, 7 in ILN/1:22-cv-01696, 7 in ILN/1:22-cv-01717, 7 in INN/1:22-cv-00116, 7 in LAM/3:22-cv-00210, 7 in MA/3:22-cv-10006, #10 in MDL No. 3036, 7 in MIE/5:21-cv-12324, 7 in NCM/1:22-cv-00212, 7 in NCW/3:22-cv-00117, 7 in NCW/5:22-cv-00030, 7 in NJ/3:22-cv-00116, 7 in NV/3:21-cv-00166, 7 in RI/1:20-cv-00364, 7 in SC/2:21-cv-02211, 7 in TXE/6:21-cv-00506, 7 in TXN/4:22-cv-00241, 7 in WIW/3:20-cv-01048, 7 in WVS/2:22-cv-00160), (6 in AZ/2:20-cv-01425, 6 in AZ/2:22-cv-00398, 6 in AZ/2:22-cv-00420, 6 in CAC/2:22-cv-01739, 6 in CAC/8:22-cv-00422, 6 in CAC/8:22-cv-00431, 6 in CAS/3:21-cv-00120, 6 in FLM/8:21-cv-01814, 6 in FLM/8:21-cv-02903, 6 in FLN/3:21-cv-01335, 6 in FLS/9:22-cv-80445, 6 in GAN/1:22-cv-01171, 6 in GAN/1:22-cv-01178, 6 in HI/1:22-cv-00144, 6 in ILC/4:21-cv-04154, 6 in ILN/1:22-cv-01643, 6 in ILN/1:22-cv-01696, 6 in ILN/1:22-cv-01717, 6 in INN/1:22-cv-00116, 6 in LAM/3:22-cv-00210, 6 in MA/3:22-cv-10006, 9 in MDL No. 3036, 6 in MIE/5:21-cv-12324, 6 in NCM/1:22-cv-00212, 6 in NCW/3:22-cv-00117, 6 in NCW/5:22-cv-00030, 6 in NJ/3:22-cv-00116, 6 in NV/3:21-cv-00166, 6 in RI/1:20-cv-00364, 6 in SC/2:21-cv-02211, 6 in TXE/6:21-cv-00506, 6 in TXN/4:22-cv-00241, 6 in WIW/3:20-cv-01048, 6 in WVS/2:22-cv-00160), (4 in AZ/2:20-cv-01425, 4 in AZ/2:22-cv-00398, 4 in AZ/2:22-cv-00420, 4 in CAC/2:22-cv-01739, 4 in CAC/8:22-cv-00422, 4 in CAC/8:22-cv-00431, 4 in CAS/3:21-cv-00120, 4 in FLM/8:21-cv-01814, 4 in FLM/8:21-cv-02903, 4 in FLN/3:21-cv-01335, 4 in FLS/9:22-cv-80445, 4 in GAN/1:22-cv-01171, 4 in GAN/1:22-cv-01178, 4 in HI/1:22-cv-00144, 4 in ILC/4:21-cv-04154, 4 in ILN/1:22-cv-01643, 4 in ILN/1:22-cv-01696, 4 in ILN/1:22-cv-01717, 4 in INN/1:22-cv-00116, 4 in LAM/3:22-cv-00210, 4 in MA/3:22-cv-10006, #7 in MDL No. 3036, 4 in MIE/5:21-cv-12324, 4 in NCM/1:22-cv-00212, 4 in NCW/3:22-cv-00117, 4 in NCW/5:22-cv-00030, 4 in NJ/3:22-cv-00116, 4 in NV/3:21-cv-00166, 4 in RI/1:20-cv-00364, 4 in SC/2:21-cv-02211, 4 in TXE/6:21-cv-00506, 4 in TXN/4:22-cv-00241, 4 in WIW/3:20-cv-01048, 4 in WVS/2:22-cv-00160), (5 in AZ/2:20-cv-01425, 5 in AZ/2:22-cv-00398, 5 in AZ/2:22-cv-00420, 5 in CAC/2:22-cv-01739, 5 in CAC/8:22-cv-00422, 5 in CAC/8:22-cv-00431, 5 in CAS/3:21-cv-00120, 5 in FLM/8:21-cv-01814, 5 in FLM/8:21-cv-02903, 5 in FLN/3:21-cv-01335, 5 in FLS/9:22-cv-80445, 5 in GAN/1:22-cv-01171, 5 in GAN/1:22-cv-01178, 5 in HI/1:22-cv-00144, 5 in ILC/4:21-cv-04154, 5 in ILN/1:22-cv-01643, 5 in ILN/1:22-cv-01696, 5 in ILN/1:22-cv-01717, 5 in INN/1:22-cv-00116, 5 in LAM/3:22-cv-00210, 5 in MA/3:22-cv-10006, #8 in MDL No. 3036, 5 in MIE/5:21-cv-12324, 5 in NCM/1:22-cv-00212, 5 in NCW/3:22-cv-00117, 5 in NCW/5:22-cv-00030, 5 in NJ/3:22-cv-00116, 5 in NV/3:21-cv-00166, 5 in RI/1:20-cv-00364, 5 in SC/2:21-cv-02211, 5 in TXE/6:21-cv-00506, 5 in TXN/4:22-cv-00241, 5 in WIW/3:20-cv-01048, 5 in WVS/2:22-cv-00160) - Filed by Defendants Merck & Co., Inc., Merck Sharp & Dohme Corp. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED DUPLICATE PARTY NAMES Modified on 4/22/2022 (CMD). |
Filing 7 MOTION FOR EXTENSION OF TIME TO FILE RESPONSE re: pldg. ( 3 in MDL No. 3036), ( #1 in MDL No. 3036), ( #4 in MDL No. 3036) Filed by Allyson Julien on behalf of Defendants Merck Sharp & Dohme Corp., #et al.Merck & Co., Inc. #[Suppress List] (Attachments: #1 Declaration, #2 Schedule of Actions, #3 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED DUPLICATE PARTY NAMES Modified on 4/21/2022 (CMD). |
Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 3036) -- Identifying Corporate Parent MERCK & CO., INC., for MERCK SHARP & DOHME CORP.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED MDL LINKS & DUPLICATE PARTY NAME Modified on 4/21/2022 (CMD). |
Filing 5 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 3036) -- Identifying Corporate Parent No Parent Corporation for Merck & Co, Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED MDL LINKS & DUPLICATE PARTY NAME Modified on 4/21/2022 (CMD). |
Filing 4 NOTICE OF APPEARANCE re: pldg.( 3 in MDL No. 3036), ( #1 in MDL No. 3036), ( #4 in MDL No. 3036) Filed by Allyson Julien on behalf of Defendants Merck Sharp & Dohme Corp., Merck & Co., Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED DUPLICATE PARTY NAMES Modified on 4/21/2022 (CMD). |
Filing 3 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 3036) BRIEFING SCHEDULE IS SET AS FOLLOWS:< br< Notices of Appearance due on or before 4/29/2022. Corporate Disclosure Statements due on or before 4/29/2022. Responses due on or before 5/6/2022. Reply, if any, due on or before 5/13/2022. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines < Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 4/15/2022. Associated Cases: MDL No. 3036, AZ/2:20-cv-01425, AZ/2:22-cv-00398, AZ/2:22-cv-00420, CAC/2:22-cv-01739, CAC/8:22-cv-00422, CAC/8:22-cv-00431, CAS/3:21-cv-00120, FLM/8:21-cv-01814, FLM/8:21-cv-02903, FLN/3:21-cv-01335, FLS/9:22-cv-80445, GAN/1:22-cv-01171, GAN/1:22-cv-01178, HI/1:22-cv-00144, ILC/4:21-cv-04154, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, MA/3:22-cv-10006, MIE/5:21-cv-12324, NCM/1:22-cv-00212, NCW/3:22-cv-00117, NCW/5:22-cv-00030, NJ/3:22-cv-00116, NV/3:21-cv-00166, RI/1:20-cv-00364, SC/2:21-cv-02211, TXE/6:21-cv-00506, TXN/4:22-cv-00241, WIW/3:20-cv-01048, WVS/2:22-cv-00160 (CMD) |
Filing 2 MDL Number 3036 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 76) Associated Cases: Pending No. 76, AZ/2:20-cv-01425, AZ/2:22-cv-00398, AZ/2:22-cv- 00420, CAC/2:22-cv-01739, CAC/8:22-cv-00422, CAC/8:22-cv-00431, CAS/3:21-cv-00120, FLM/8:21-cv-01814, FLM/8:21-cv-02903, FLN/3:21-cv-01335, FLS/9:22-cv-80445, GAN/1:22-cv-01171, GAN/1:22-cv-01178, HI/1:22-cv-00144, ILC/4:21-cv-04154, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, MA/3:22-cv-10006, MIE/5:21-cv-12324, NCM/1:22-cv-00212, NCW/3:22-cv-00117, NCW/5:22-cv-00030, NJ/3:22-cv-00116, NV/3:21-cv-00166, RI/1:20-cv-00364, SC/2:21-cv-02211, TXE/6:21-cv-00506, TXN/4:22-cv-00241, WIW/3:20-cv-01048, WVS/2:22-cv-00160 (CMD) |
Filing 1 SEE CORRECTED PLDG. 4CERTIFICATE OF SERVICE re: pldg. ( #1 in Pending No. 76) Associated Cases: Pending No. 76 et al. (Esfandiari, Bijan) Modified on 4/15/2022 (CMD). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.